Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Igm Biosciences Inc (NQ: IGMS )

15.38 -0.70 (-4.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 187,406
Open 15.88
Bid (Size) 14.25 (7)
Ask (Size) 16.67 (1)
Prev. Close 16.08
Today's Range 15.22 - 16.04
52wk Range 12.67 - 35.98
Shares Outstanding 25,905,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
From IGM Biosciences, Inc.
Via Globe NewsWire

Performance

YTD
-9.26%
-9.26%
1 Month
-27.56%
-27.56%
3 Month
-0.45%
-0.45%
6 Month
-18.02%
-18.02%
1 Year
+2.60%
+2.60%

More News

Read More
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences's Return On Capital Employed Overview
Via Benzinga
IGM Biosciences: Q2 Earnings Insights
Via Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Analyst Ratings for IGM Biosciences
Via Benzinga
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference
From IGM Biosciences, Inc.
Via Globe NewsWire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Via Benzinga
$10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
From IGM Biosciences, Inc.
Via Globe NewsWire
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Via Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Via Benzinga
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.